The USC Biomedical Simulations Resource (BMSR), USC Viterbi’s longest continuously funded NIH-research center, has since 1985 produced software like ADAPT, used in the development of Herceptin – the first biologic developed for the treatment of breast cancer, as well as Rituxan for treating non-Hodgkin’s lymphoma.